BASF and Poietis sign new 3D bioprinting agreement

BASF and Poietis sign new 3D bioprinting agreement

Two years after their first official collaboration, BASF and Poietis have announced they have signed a framework agreement to further develop the field of 3D bioprinting technology.

“During our cooperation, we gained important insights… In a second step, we now want to jointly improve the skin models by increasing structure complexity and adding new cell types,” said BASF’s Sebastien Cadau.

“This agreement confirms a fruitful scientific collaboration and strengthens our partnership with the leading ingredients manufacturer for the personal care market. This is a formal recognition of Poietis’ unique technology and its valorization driven by new developments since the creation of the company,” added Bruno Brisson, Poietis Co-Founder and Vice President Business Development.


Leave a reply

Your email address will not be published. Required fields are marked *